4:05 PM
 | 
May 02, 2019
 |  BC Innovations  |  Translation in Brief

Public funding highlights

Public funding highlights

Selected developments and initiatives in 1Q19 from major sources of public funding including National Institutes of Health (NIH), the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of Health Research (CIHR), the Agency for Science Technology and Research (A*STAR) and the Japan Agency for Medical Research and Development (AMED).

DateAgencySummaryType
Jan. 9EU Joint Programme - Neurodegenerative Disease Research (JPND)A €30 million ($33.5 million) call for proposals by EU’s JPND will support precision medicine projects for neurodegenerative diseases, covering diagnostics, prevention and care.Grant
Jan. 10AMED; MRCA £10 million ($12.9 million) partnership between MRC and AMED will support joint research projects between U.K. and Japanese academics and businesses in degenerative diseases and assisted living products.Strategy
Jan. 22IMIIMI’s latest €83.9 million ($93.6 million) call for proposals includes grants for research for better characterizing obesity...

Read the full 813 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$100 USD
More Info >